Browse diseases

…target, particularly in metabolically repressive tumors such as pancreatic cancer.…

…st solid tumors.References Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer . Lancet. 2004;363:1049–57.Siegel RL, Kratzer TB, Giaquinto AN.…

…otoxicity with potent immunotherapeutic properties for treating pancreatic cancer, enabling a multipronged, potentially safer treatment for a bro…

…ever, no statistically significant association was observed for pancreatic cancer (HR 1.26; 95% CI: 0.87-1.82; p=0.224). Additionally, the elevat…

… radiological follow-up was used as the reference standard. For pancreatic cancer, biopsy results were considered positive only when definitive m…

…verall and based on stricture location). Looking exclusively at pancreatic cancer and cholangiocarcinoma cohort, sensitivity was 59% & 39% respec…

…t mass in the cauda of the pancreas.According to Shields et al, pancreatic cancer with uveal metastasis has one of the least favourable survival …

… cancers (p<0.05), whereas no beneficial trend was detected for pancreatic cancer. Subgroup analyses indicated persistently lower screening parti…

…Background Immunotherapy has had limited success in pancreatic cancer, largely due to a low mutational burden and immunosuppressive m…

…-year mortality and double diagnostic activities was found. For pancreatic cancer, one CCN showed a significant decrease in 2-year oncological co…

…Background Diagnosing the presence of metastasis of pancreatic cancer is pivotal for patient management and treatment, with contrast-…

…Background Pancreatic cancer is traditionally considered an ‘immune cold’ tumor. Although ou…